nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMP—urinary bladder cancer	0.285	0.68	CbGaD
Floxuridine—Decitabine—Gemcitabine—urinary bladder cancer	0.151	1	CrCrCtD
Floxuridine—TYMS—urinary bladder cancer	0.134	0.32	CbGaD
Floxuridine—TYMP—Fluorouracil—urinary bladder cancer	0.132	0.409	CbGbCtD
Floxuridine—TYMS—Gemcitabine—urinary bladder cancer	0.0821	0.254	CbGbCtD
Floxuridine—TYMS—Fluorouracil—urinary bladder cancer	0.0703	0.217	CbGbCtD
Floxuridine—TYMS—Methotrexate—urinary bladder cancer	0.0387	0.12	CbGbCtD
Floxuridine—TYMP—Bladder Cancer—RASSF1—urinary bladder cancer	0.0028	0.0792	CbGpPWpGaD
Floxuridine—TYMP—prostate gland—urinary bladder cancer	0.00168	0.139	CbGeAlD
Floxuridine—TYMS—prostate gland—urinary bladder cancer	0.00144	0.119	CbGeAlD
Floxuridine—TYMP—seminal vesicle—urinary bladder cancer	0.00142	0.117	CbGeAlD
Floxuridine—TYMP—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.00138	0.039	CbGpPWpGaD
Floxuridine—TYMS—G1/S-Specific Transcription—RRM2—urinary bladder cancer	0.0012	0.0339	CbGpPWpGaD
Floxuridine—TYMP—smooth muscle tissue—urinary bladder cancer	0.00119	0.0981	CbGeAlD
Floxuridine—TYMS—Pyrimidine metabolism—TYMP—urinary bladder cancer	0.00116	0.0329	CbGpPWpGaD
Floxuridine—TYMP—urethra—urinary bladder cancer	0.00112	0.0928	CbGeAlD
Floxuridine—TYMP—Pyrimidine metabolism—TYMS—urinary bladder cancer	0.00103	0.0291	CbGpPWpGaD
Floxuridine—TYMS—smooth muscle tissue—urinary bladder cancer	0.00102	0.0842	CbGeAlD
Floxuridine—TYMP—female reproductive system—urinary bladder cancer	0.000917	0.0757	CbGeAlD
Floxuridine—TYMS—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.000902	0.0255	CbGpPWpGaD
Floxuridine—Trifluridine—TYMP—urinary bladder cancer	0.000831	0.318	CrCbGaD
Floxuridine—TYMP—vagina—urinary bladder cancer	0.000829	0.0684	CbGeAlD
Floxuridine—TYMP—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000796	0.0226	CbGpPWpGaD
Floxuridine—TYMS—female reproductive system—urinary bladder cancer	0.000787	0.0649	CbGeAlD
Floxuridine—TYMS—Podofilox—Etoposide—urinary bladder cancer	0.000755	0.713	CbGdCrCtD
Floxuridine—TYMP—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.00074	0.021	CbGpPWpGaD
Floxuridine—TYMS—vagina—urinary bladder cancer	0.000711	0.0587	CbGeAlD
Floxuridine—TYMS—G1/S-Specific Transcription—CCNE1—urinary bladder cancer	0.000705	0.02	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000704	0.0199	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—RRM2—urinary bladder cancer	0.000704	0.0199	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000696	0.0197	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000691	0.0196	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—FGFR3—urinary bladder cancer	0.000669	0.019	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDK4—urinary bladder cancer	0.000653	0.0185	CbGpPWpGaD
Floxuridine—Zidovudine—TERT—urinary bladder cancer	0.000576	0.22	CrCbGaD
Floxuridine—TYMP—Bladder Cancer—RB1—urinary bladder cancer	0.000568	0.0161	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDH1—urinary bladder cancer	0.000566	0.016	CbGpPWpGaD
Floxuridine—TYMP—lymph node—urinary bladder cancer	0.000536	0.0443	CbGeAlD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—urinary bladder cancer	0.000499	0.0141	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—ERBB2—urinary bladder cancer	0.000477	0.0135	CbGpPWpGaD
Floxuridine—TYMS—lymph node—urinary bladder cancer	0.00046	0.038	CbGeAlD
Floxuridine—TYMS—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000453	0.0128	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CXCL8—urinary bladder cancer	0.000453	0.0128	CbGpPWpGaD
Floxuridine—Zidovudine—UGT2B7—urinary bladder cancer	0.000448	0.171	CrCbGaD
Floxuridine—TYMP—Bladder Cancer—CCND1—urinary bladder cancer	0.000422	0.0119	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—CCNE1—urinary bladder cancer	0.000415	0.0117	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—XRCC1—urinary bladder cancer	0.000414	0.0117	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDKN1A—urinary bladder cancer	0.000408	0.0115	CbGpPWpGaD
Floxuridine—TYMS—One Carbon Metabolism—MTHFR—urinary bladder cancer	0.000406	0.0115	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—TYMS—urinary bladder cancer	0.0004	0.0113	CbGpPWpGaD
Floxuridine—Trifluridine—TYMS—urinary bladder cancer	0.000391	0.149	CrCbGaD
Floxuridine—TYMP—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000379	0.0107	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000379	0.0107	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—RRM2—urinary bladder cancer	0.000373	0.0106	CbGpPWpGaD
Floxuridine—Cladribine—RRM2—urinary bladder cancer	0.000371	0.142	CrCbGaD
Floxuridine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—urinary bladder cancer	0.000365	0.0103	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000356	0.0101	CbGpPWpGaD
Floxuridine—TYMS—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000354	0.01	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MYC—urinary bladder cancer	0.000338	0.00957	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—EGFR—urinary bladder cancer	0.000331	0.00937	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000324	0.00918	CbGpPWpGaD
Floxuridine—TYMS—Azacitidine—Gemcitabine—urinary bladder cancer	0.000304	0.287	CbGdCrCtD
Floxuridine—TYMS—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.000298	0.00844	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—TP53—urinary bladder cancer	0.000278	0.00786	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—RB1—urinary bladder cancer	0.000276	0.00782	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000276	0.0078	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—RRM2—urinary bladder cancer	0.000271	0.00766	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—HRAS—urinary bladder cancer	0.000266	0.00752	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000264	0.00748	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—SMC1B—urinary bladder cancer	0.000234	0.00663	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—RRM2—urinary bladder cancer	0.000228	0.00646	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CCNE1—urinary bladder cancer	0.00022	0.00622	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00021	0.00594	CbGpPWpGaD
Floxuridine—TYMS—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000194	0.00549	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000191	0.00541	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—PLAU—urinary bladder cancer	0.000178	0.00504	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—ATM—urinary bladder cancer	0.000169	0.00479	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00016	0.00453	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—CCNE1—urinary bladder cancer	0.000159	0.00452	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000159	0.0045	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CREBBP—urinary bladder cancer	0.000147	0.00416	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—RB1—urinary bladder cancer	0.000146	0.00414	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000146	0.00414	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTZ1—urinary bladder cancer	0.00014	0.00397	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000135	0.00383	CbGpPWpGaD
Floxuridine—Erythema—Thiotepa—urinary bladder cancer	0.000135	0.00246	CcSEcCtD
Floxuridine—Lacrimation increased—Epirubicin—urinary bladder cancer	0.000135	0.00246	CcSEcCtD
Floxuridine—Glossitis—Epirubicin—urinary bladder cancer	0.000135	0.00246	CcSEcCtD
Floxuridine—Epistaxis—Fluorouracil—urinary bladder cancer	0.000135	0.00245	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCNE1—urinary bladder cancer	0.000134	0.00381	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000134	0.00379	CbGpPWpGaD
Floxuridine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000133	0.00243	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTO2—urinary bladder cancer	0.000133	0.00376	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NAT1—urinary bladder cancer	0.000133	0.00376	CbGpPWpGaD
Floxuridine—Pancytopenia—Etoposide—urinary bladder cancer	0.000132	0.00241	CcSEcCtD
Floxuridine—Stomatitis—Cisplatin—urinary bladder cancer	0.000132	0.0024	CcSEcCtD
Floxuridine—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000131	0.00239	CcSEcCtD
Floxuridine—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000131	0.00238	CcSEcCtD
Floxuridine—Nausea—Mitomycin—urinary bladder cancer	0.00013	0.00237	CcSEcCtD
Floxuridine—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00013	0.00236	CcSEcCtD
Floxuridine—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000129	0.00235	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—urinary bladder cancer	0.000129	0.00364	CbGpPWpGaD
Floxuridine—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000128	0.00234	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000128	0.00363	CbGpPWpGaD
Floxuridine—Pharyngitis—Fluorouracil—urinary bladder cancer	0.000127	0.00232	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.000127	0.0036	CbGpPWpGaD
Floxuridine—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.000125	0.00227	CcSEcCtD
Floxuridine—Glossitis—Doxorubicin—urinary bladder cancer	0.000125	0.00227	CcSEcCtD
Floxuridine—Anaemia—Thiotepa—urinary bladder cancer	0.000125	0.00227	CcSEcCtD
Floxuridine—TYMP—Metabolism—UGT2B7—urinary bladder cancer	0.000121	0.00344	CbGpPWpGaD
Floxuridine—Stomatitis—Etoposide—urinary bladder cancer	0.000121	0.0022	CcSEcCtD
Floxuridine—Leukopenia—Thiotepa—urinary bladder cancer	0.000121	0.0022	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—ESPL1—urinary bladder cancer	0.00012	0.00339	CbGpPWpGaD
Floxuridine—Agranulocytosis—Etoposide—urinary bladder cancer	0.000116	0.00211	CcSEcCtD
Floxuridine—Alopecia—Gemcitabine—urinary bladder cancer	0.000115	0.0021	CcSEcCtD
Floxuridine—Erythema—Gemcitabine—urinary bladder cancer	0.000114	0.00207	CcSEcCtD
Floxuridine—Alopecia—Fluorouracil—urinary bladder cancer	0.000113	0.00206	CcSEcCtD
Floxuridine—Rash maculo-papular—Epirubicin—urinary bladder cancer	0.000113	0.00206	CcSEcCtD
Floxuridine—Erythema—Fluorouracil—urinary bladder cancer	0.000112	0.00203	CcSEcCtD
Floxuridine—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.000112	0.00203	CcSEcCtD
Floxuridine—Confusional state—Thiotepa—urinary bladder cancer	0.000111	0.00202	CcSEcCtD
Floxuridine—Photosensitivity—Methotrexate—urinary bladder cancer	0.00011	0.002	CcSEcCtD
Floxuridine—Infection—Thiotepa—urinary bladder cancer	0.00011	0.00199	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP4B1—urinary bladder cancer	0.000109	0.0031	CbGpPWpGaD
Floxuridine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000108	0.00197	CcSEcCtD
Floxuridine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000108	0.00196	CcSEcCtD
Floxuridine—Alopecia—Cisplatin—urinary bladder cancer	0.000108	0.00196	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—RB1—urinary bladder cancer	0.000106	0.00301	CbGpPWpGaD
Floxuridine—Erythema—Cisplatin—urinary bladder cancer	0.000106	0.00193	CcSEcCtD
Floxuridine—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000105	0.00192	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN1A—urinary bladder cancer	0.000105	0.00298	CbGpPWpGaD
Floxuridine—Anorexia—Thiotepa—urinary bladder cancer	0.000105	0.00191	CcSEcCtD
Floxuridine—Anaemia—Gemcitabine—urinary bladder cancer	0.000105	0.00191	CcSEcCtD
Floxuridine—Rash maculo-papular—Doxorubicin—urinary bladder cancer	0.000105	0.0019	CcSEcCtD
Floxuridine—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.000104	0.0019	CcSEcCtD
Floxuridine—Anaemia—Fluorouracil—urinary bladder cancer	0.000103	0.00188	CcSEcCtD
Floxuridine—TYMP—Metabolism—SLC19A1—urinary bladder cancer	0.000103	0.00292	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDK4—urinary bladder cancer	0.000103	0.00291	CbGpPWpGaD
Floxuridine—Photosensitivity—Epirubicin—urinary bladder cancer	0.000103	0.00187	CcSEcCtD
Floxuridine—Malaise—Gemcitabine—urinary bladder cancer	0.000103	0.00186	CcSEcCtD
Floxuridine—Muscle spasms—Cisplatin—urinary bladder cancer	0.000102	0.00185	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000102	0.00288	CbGpPWpGaD
Floxuridine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000102	0.00185	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.000102	0.00288	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000102	0.00288	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PRSS3—urinary bladder cancer	0.000101	0.00285	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—EP300—urinary bladder cancer	0.0001	0.00283	CbGpPWpGaD
Floxuridine—Leukopenia—Fluorouracil—urinary bladder cancer	0.0001	0.00182	CcSEcCtD
Floxuridine—Alopecia—Etoposide—urinary bladder cancer	9.85e-05	0.00179	CcSEcCtD
Floxuridine—Lethargy—Methotrexate—urinary bladder cancer	9.85e-05	0.00179	CcSEcCtD
Floxuridine—Ill-defined disorder—Cisplatin—urinary bladder cancer	9.83e-05	0.00179	CcSEcCtD
Floxuridine—Anaemia—Cisplatin—urinary bladder cancer	9.79e-05	0.00178	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	9.66e-05	0.00176	CcSEcCtD
Floxuridine—Decreased appetite—Thiotepa—urinary bladder cancer	9.59e-05	0.00174	CcSEcCtD
Floxuridine—Discomfort—Gemcitabine—urinary bladder cancer	9.56e-05	0.00174	CcSEcCtD
Floxuridine—Malaise—Cisplatin—urinary bladder cancer	9.55e-05	0.00174	CcSEcCtD
Floxuridine—Photosensitivity—Doxorubicin—urinary bladder cancer	9.52e-05	0.00173	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—NCOR1—urinary bladder cancer	9.49e-05	0.00269	CbGpPWpGaD
Floxuridine—Leukopenia—Cisplatin—urinary bladder cancer	9.48e-05	0.00173	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	9.45e-05	0.00267	CbGpPWpGaD
Floxuridine—Discomfort—Fluorouracil—urinary bladder cancer	9.4e-05	0.00171	CcSEcCtD
Floxuridine—Muscle spasms—Etoposide—urinary bladder cancer	9.33e-05	0.0017	CcSEcCtD
Floxuridine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	9.28e-05	0.00169	CcSEcCtD
Floxuridine—Lethargy—Epirubicin—urinary bladder cancer	9.22e-05	0.00168	CcSEcCtD
Floxuridine—Infection—Gemcitabine—urinary bladder cancer	9.22e-05	0.00168	CcSEcCtD
Floxuridine—Confusional state—Fluorouracil—urinary bladder cancer	9.2e-05	0.00167	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	9.14e-05	0.00259	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	9.12e-05	0.00166	CcSEcCtD
Floxuridine—Nervous system disorder—Gemcitabine—urinary bladder cancer	9.1e-05	0.00166	CcSEcCtD
Floxuridine—Feeling abnormal—Thiotepa—urinary bladder cancer	9.09e-05	0.00165	CcSEcCtD
Floxuridine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	9.08e-05	0.00165	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—STAG2—urinary bladder cancer	9.08e-05	0.00257	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—LIG1—urinary bladder cancer	9.08e-05	0.00257	CbGpPWpGaD
Floxuridine—Infection—Fluorouracil—urinary bladder cancer	9.06e-05	0.00165	CcSEcCtD
Floxuridine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	9.02e-05	0.00164	CcSEcCtD
Floxuridine—Ill-defined disorder—Etoposide—urinary bladder cancer	9.01e-05	0.00164	CcSEcCtD
Floxuridine—Anaemia—Etoposide—urinary bladder cancer	8.97e-05	0.00163	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—RB1—urinary bladder cancer	8.95e-05	0.00253	CbGpPWpGaD
Floxuridine—Nervous system disorder—Fluorouracil—urinary bladder cancer	8.95e-05	0.00163	CcSEcCtD
Floxuridine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	8.93e-05	0.00162	CcSEcCtD
Floxuridine—Discomfort—Cisplatin—urinary bladder cancer	8.91e-05	0.00162	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.86e-05	0.00251	CbGpPWpGaD
Floxuridine—Anorexia—Gemcitabine—urinary bladder cancer	8.84e-05	0.00161	CcSEcCtD
Floxuridine—Malaise—Etoposide—urinary bladder cancer	8.75e-05	0.00159	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—MYC—urinary bladder cancer	8.72e-05	0.00247	CbGpPWpGaD
Floxuridine—Body temperature increased—Thiotepa—urinary bladder cancer	8.72e-05	0.00159	CcSEcCtD
Floxuridine—Abdominal pain—Thiotepa—urinary bladder cancer	8.72e-05	0.00159	CcSEcCtD
Floxuridine—Anorexia—Fluorouracil—urinary bladder cancer	8.69e-05	0.00158	CcSEcCtD
Floxuridine—Leukopenia—Etoposide—urinary bladder cancer	8.69e-05	0.00158	CcSEcCtD
Floxuridine—Anaphylactic shock—Cisplatin—urinary bladder cancer	8.65e-05	0.00157	CcSEcCtD
Floxuridine—Infection—Cisplatin—urinary bladder cancer	8.59e-05	0.00156	CcSEcCtD
Floxuridine—Lethargy—Doxorubicin—urinary bladder cancer	8.53e-05	0.00155	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—FAS—urinary bladder cancer	8.51e-05	0.00241	CbGpPWpGaD
Floxuridine—Nervous system disorder—Cisplatin—urinary bladder cancer	8.48e-05	0.00154	CcSEcCtD
Floxuridine—Thrombocytopenia—Cisplatin—urinary bladder cancer	8.47e-05	0.00154	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	8.36e-05	0.00237	CbGpPWpGaD
Floxuridine—Dry skin—Epirubicin—urinary bladder cancer	8.28e-05	0.00151	CcSEcCtD
Floxuridine—Anorexia—Cisplatin—urinary bladder cancer	8.24e-05	0.0015	CcSEcCtD
Floxuridine—Discomfort—Etoposide—urinary bladder cancer	8.16e-05	0.00149	CcSEcCtD
Floxuridine—Hypersensitivity—Thiotepa—urinary bladder cancer	8.13e-05	0.00148	CcSEcCtD
Floxuridine—Decreased appetite—Gemcitabine—urinary bladder cancer	8.06e-05	0.00147	CcSEcCtD
Floxuridine—Gastritis—Epirubicin—urinary bladder cancer	8e-05	0.00145	CcSEcCtD
Floxuridine—Confusional state—Etoposide—urinary bladder cancer	7.99e-05	0.00145	CcSEcCtD
Floxuridine—Decreased appetite—Fluorouracil—urinary bladder cancer	7.93e-05	0.00144	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—urinary bladder cancer	7.92e-05	0.00144	CcSEcCtD
Floxuridine—Anaphylactic shock—Etoposide—urinary bladder cancer	7.92e-05	0.00144	CcSEcCtD
Floxuridine—Asthenia—Thiotepa—urinary bladder cancer	7.91e-05	0.00144	CcSEcCtD
Floxuridine—Infection—Etoposide—urinary bladder cancer	7.87e-05	0.00143	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—urinary bladder cancer	7.87e-05	0.00223	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.83e-05	0.00222	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.8e-05	0.00221	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.77e-05	0.0022	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Etoposide—urinary bladder cancer	7.76e-05	0.00141	CcSEcCtD
Floxuridine—Dry skin—Doxorubicin—urinary bladder cancer	7.66e-05	0.00139	CcSEcCtD
Floxuridine—Feeling abnormal—Gemcitabine—urinary bladder cancer	7.64e-05	0.00139	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1A—urinary bladder cancer	7.63e-05	0.00216	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	7.62e-05	0.00139	CcSEcCtD
Floxuridine—Angina pectoris—Epirubicin—urinary bladder cancer	7.61e-05	0.00138	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	7.58e-05	0.00215	CbGpPWpGaD
Floxuridine—Anorexia—Etoposide—urinary bladder cancer	7.55e-05	0.00137	CcSEcCtD
Floxuridine—Diarrhoea—Thiotepa—urinary bladder cancer	7.55e-05	0.00137	CcSEcCtD
Floxuridine—Decreased appetite—Cisplatin—urinary bladder cancer	7.52e-05	0.00137	CcSEcCtD
Floxuridine—Feeling abnormal—Fluorouracil—urinary bladder cancer	7.52e-05	0.00137	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—CDK4—urinary bladder cancer	7.49e-05	0.00212	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—RRM2—urinary bladder cancer	7.48e-05	0.00212	CbGpPWpGaD
Floxuridine—Pancytopenia—Epirubicin—urinary bladder cancer	7.42e-05	0.00135	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—urinary bladder cancer	7.4e-05	0.00135	CcSEcCtD
Floxuridine—Body temperature increased—Gemcitabine—urinary bladder cancer	7.33e-05	0.00133	CcSEcCtD
Floxuridine—TYMP—Metabolism—NAT2—urinary bladder cancer	7.28e-05	0.00206	CbGpPWpGaD
Floxuridine—Stomatitis—Methotrexate—urinary bladder cancer	7.25e-05	0.00132	CcSEcCtD
Floxuridine—Body temperature increased—Fluorouracil—urinary bladder cancer	7.21e-05	0.00131	CcSEcCtD
Floxuridine—TYMS—Metabolism—GSTZ1—urinary bladder cancer	7.17e-05	0.00203	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	7.13e-05	0.0013	CcSEcCtD
Floxuridine—Feeling abnormal—Cisplatin—urinary bladder cancer	7.13e-05	0.0013	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	7.11e-05	0.00201	CbGpPWpGaD
Floxuridine—Angina pectoris—Doxorubicin—urinary bladder cancer	7.04e-05	0.00128	CcSEcCtD
Floxuridine—Epistaxis—Methotrexate—urinary bladder cancer	7.02e-05	0.00128	CcSEcCtD
Floxuridine—Vomiting—Thiotepa—urinary bladder cancer	7.01e-05	0.00128	CcSEcCtD
Floxuridine—Rash—Thiotepa—urinary bladder cancer	6.95e-05	0.00127	CcSEcCtD
Floxuridine—Dermatitis—Thiotepa—urinary bladder cancer	6.95e-05	0.00126	CcSEcCtD
Floxuridine—Agranulocytosis—Methotrexate—urinary bladder cancer	6.94e-05	0.00126	CcSEcCtD
Floxuridine—Headache—Thiotepa—urinary bladder cancer	6.91e-05	0.00126	CcSEcCtD
Floxuridine—Decreased appetite—Etoposide—urinary bladder cancer	6.89e-05	0.00125	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—urinary bladder cancer	6.86e-05	0.00125	CcSEcCtD
Floxuridine—Body temperature increased—Cisplatin—urinary bladder cancer	6.84e-05	0.00124	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.81e-05	0.00193	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—PPARG—urinary bladder cancer	6.8e-05	0.00193	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NAT1—urinary bladder cancer	6.79e-05	0.00192	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTO2—urinary bladder cancer	6.79e-05	0.00192	CbGpPWpGaD
Floxuridine—Stomatitis—Epirubicin—urinary bladder cancer	6.79e-05	0.00123	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.72e-05	0.0019	CbGpPWpGaD
Floxuridine—Hypersensitivity—Fluorouracil—urinary bladder cancer	6.72e-05	0.00122	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—urinary bladder cancer	6.71e-05	0.00122	CcSEcCtD
Floxuridine—Haemorrhage—Methotrexate—urinary bladder cancer	6.68e-05	0.00122	CcSEcCtD
Floxuridine—Asthenia—Gemcitabine—urinary bladder cancer	6.66e-05	0.00121	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—urinary bladder cancer	6.65e-05	0.00188	CbGpPWpGaD
Floxuridine—Pharyngitis—Methotrexate—urinary bladder cancer	6.63e-05	0.00121	CcSEcCtD
Floxuridine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	6.6e-05	0.0012	CcSEcCtD
Floxuridine—Epistaxis—Epirubicin—urinary bladder cancer	6.57e-05	0.00119	CcSEcCtD
Floxuridine—Nausea—Thiotepa—urinary bladder cancer	6.55e-05	0.00119	CcSEcCtD
Floxuridine—Feeling abnormal—Etoposide—urinary bladder cancer	6.53e-05	0.00119	CcSEcCtD
Floxuridine—Agranulocytosis—Epirubicin—urinary bladder cancer	6.5e-05	0.00118	CcSEcCtD
Floxuridine—Gastrointestinal pain—Etoposide—urinary bladder cancer	6.48e-05	0.00118	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—urinary bladder cancer	6.43e-05	0.00182	CbGpPWpGaD
Floxuridine—Hypersensitivity—Cisplatin—urinary bladder cancer	6.37e-05	0.00116	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—SMC1A—urinary bladder cancer	6.36e-05	0.0018	CbGpPWpGaD
Floxuridine—Diarrhoea—Gemcitabine—urinary bladder cancer	6.35e-05	0.00115	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—MYC—urinary bladder cancer	6.33e-05	0.00179	CbGpPWpGaD
Floxuridine—Haemoglobin—Epirubicin—urinary bladder cancer	6.28e-05	0.00114	CcSEcCtD
Floxuridine—TYMP—Metabolism—RRM2—urinary bladder cancer	6.28e-05	0.00178	CbGpPWpGaD
Floxuridine—Stomatitis—Doxorubicin—urinary bladder cancer	6.28e-05	0.00114	CcSEcCtD
Floxuridine—Abdominal pain—Etoposide—urinary bladder cancer	6.26e-05	0.00114	CcSEcCtD
Floxuridine—Body temperature increased—Etoposide—urinary bladder cancer	6.26e-05	0.00114	CcSEcCtD
Floxuridine—Haemorrhage—Epirubicin—urinary bladder cancer	6.25e-05	0.00114	CcSEcCtD
Floxuridine—Diarrhoea—Fluorouracil—urinary bladder cancer	6.24e-05	0.00114	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	6.22e-05	0.00176	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—UGT2B7—urinary bladder cancer	6.21e-05	0.00176	CbGpPWpGaD
Floxuridine—Asthenia—Cisplatin—urinary bladder cancer	6.2e-05	0.00113	CcSEcCtD
Floxuridine—Pharyngitis—Epirubicin—urinary bladder cancer	6.2e-05	0.00113	CcSEcCtD
Floxuridine—Epistaxis—Doxorubicin—urinary bladder cancer	6.08e-05	0.00111	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—urinary bladder cancer	6.01e-05	0.00109	CcSEcCtD
Floxuridine—Diarrhoea—Cisplatin—urinary bladder cancer	5.92e-05	0.00108	CcSEcCtD
Floxuridine—Alopecia—Methotrexate—urinary bladder cancer	5.9e-05	0.00107	CcSEcCtD
Floxuridine—Vomiting—Gemcitabine—urinary bladder cancer	5.9e-05	0.00107	CcSEcCtD
Floxuridine—Rash—Gemcitabine—urinary bladder cancer	5.85e-05	0.00106	CcSEcCtD
Floxuridine—Dermatitis—Gemcitabine—urinary bladder cancer	5.84e-05	0.00106	CcSEcCtD
Floxuridine—Hypersensitivity—Etoposide—urinary bladder cancer	5.84e-05	0.00106	CcSEcCtD
Floxuridine—TYMP—Metabolism—HPGDS—urinary bladder cancer	5.82e-05	0.00165	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ENO2—urinary bladder cancer	5.82e-05	0.00165	CbGpPWpGaD
Floxuridine—Erythema—Methotrexate—urinary bladder cancer	5.81e-05	0.00106	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—urinary bladder cancer	5.81e-05	0.00106	CcSEcCtD
Floxuridine—Headache—Gemcitabine—urinary bladder cancer	5.81e-05	0.00106	CcSEcCtD
Floxuridine—Vomiting—Fluorouracil—urinary bladder cancer	5.8e-05	0.00106	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—urinary bladder cancer	5.78e-05	0.00105	CcSEcCtD
Floxuridine—Rash—Fluorouracil—urinary bladder cancer	5.75e-05	0.00105	CcSEcCtD
Floxuridine—Dermatitis—Fluorouracil—urinary bladder cancer	5.75e-05	0.00105	CcSEcCtD
Floxuridine—Pharyngitis—Doxorubicin—urinary bladder cancer	5.74e-05	0.00104	CcSEcCtD
Floxuridine—Headache—Fluorouracil—urinary bladder cancer	5.71e-05	0.00104	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.7e-05	0.00161	CbGpPWpGaD
Floxuridine—Asthenia—Etoposide—urinary bladder cancer	5.68e-05	0.00103	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTT1—urinary bladder cancer	5.64e-05	0.0016	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP4B1—urinary bladder cancer	5.59e-05	0.00158	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.57e-05	0.00158	CbGpPWpGaD
Floxuridine—Alopecia—Epirubicin—urinary bladder cancer	5.52e-05	0.001	CcSEcCtD
Floxuridine—Nausea—Gemcitabine—urinary bladder cancer	5.51e-05	0.001	CcSEcCtD
Floxuridine—Vomiting—Cisplatin—urinary bladder cancer	5.5e-05	0.001	CcSEcCtD
Floxuridine—Rash—Cisplatin—urinary bladder cancer	5.45e-05	0.000992	CcSEcCtD
Floxuridine—Dermatitis—Cisplatin—urinary bladder cancer	5.45e-05	0.000991	CcSEcCtD
Floxuridine—Erythema—Epirubicin—urinary bladder cancer	5.44e-05	0.00099	CcSEcCtD
Floxuridine—Diarrhoea—Etoposide—urinary bladder cancer	5.42e-05	0.000986	CcSEcCtD
Floxuridine—Nausea—Fluorouracil—urinary bladder cancer	5.42e-05	0.000986	CcSEcCtD
Floxuridine—Ill-defined disorder—Methotrexate—urinary bladder cancer	5.39e-05	0.000981	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—urinary bladder cancer	5.37e-05	0.000978	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—urinary bladder cancer	5.33e-05	0.00151	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC19A1—urinary bladder cancer	5.28e-05	0.0015	CbGpPWpGaD
Floxuridine—Malaise—Methotrexate—urinary bladder cancer	5.24e-05	0.000954	CcSEcCtD
Floxuridine—Muscle spasms—Epirubicin—urinary bladder cancer	5.23e-05	0.000952	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—urinary bladder cancer	5.2e-05	0.000947	CcSEcCtD
Floxuridine—TYMS—Metabolism—PRSS3—urinary bladder cancer	5.15e-05	0.00146	CbGpPWpGaD
Floxuridine—Nausea—Cisplatin—urinary bladder cancer	5.14e-05	0.000934	CcSEcCtD
Floxuridine—Alopecia—Doxorubicin—urinary bladder cancer	5.11e-05	0.00093	CcSEcCtD
Floxuridine—Ill-defined disorder—Epirubicin—urinary bladder cancer	5.05e-05	0.000918	CcSEcCtD
Floxuridine—Vomiting—Etoposide—urinary bladder cancer	5.04e-05	0.000916	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.04e-05	0.00143	CbGpPWpGaD
Floxuridine—Erythema—Doxorubicin—urinary bladder cancer	5.03e-05	0.000916	CcSEcCtD
Floxuridine—Anaemia—Epirubicin—urinary bladder cancer	5.03e-05	0.000915	CcSEcCtD
Floxuridine—Rash—Etoposide—urinary bladder cancer	4.99e-05	0.000909	CcSEcCtD
Floxuridine—Dermatitis—Etoposide—urinary bladder cancer	4.99e-05	0.000908	CcSEcCtD
Floxuridine—Headache—Etoposide—urinary bladder cancer	4.96e-05	0.000903	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	4.93e-05	0.0014	CbGpPWpGaD
Floxuridine—Malaise—Epirubicin—urinary bladder cancer	4.91e-05	0.000893	CcSEcCtD
Floxuridine—Discomfort—Methotrexate—urinary bladder cancer	4.89e-05	0.00089	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.87e-05	0.00138	CbGpPWpGaD
Floxuridine—Leukopenia—Epirubicin—urinary bladder cancer	4.87e-05	0.000886	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.86e-05	0.00138	CbGpPWpGaD
Floxuridine—Muscle spasms—Doxorubicin—urinary bladder cancer	4.84e-05	0.000881	CcSEcCtD
Floxuridine—Confusional state—Methotrexate—urinary bladder cancer	4.78e-05	0.00087	CcSEcCtD
Floxuridine—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.75e-05	0.000863	CcSEcCtD
Floxuridine—Infection—Methotrexate—urinary bladder cancer	4.71e-05	0.000858	CcSEcCtD
Floxuridine—Nausea—Etoposide—urinary bladder cancer	4.71e-05	0.000856	CcSEcCtD
Floxuridine—TYMP—Metabolism—NQO1—urinary bladder cancer	4.69e-05	0.00133	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.67e-05	0.00085	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—urinary bladder cancer	4.67e-05	0.00132	CbGpPWpGaD
Floxuridine—Nervous system disorder—Methotrexate—urinary bladder cancer	4.65e-05	0.000847	CcSEcCtD
Floxuridine—Anaemia—Doxorubicin—urinary bladder cancer	4.65e-05	0.000847	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.65e-05	0.000845	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.64e-05	0.00131	CbGpPWpGaD
Floxuridine—Discomfort—Epirubicin—urinary bladder cancer	4.58e-05	0.000833	CcSEcCtD
Floxuridine—Malaise—Doxorubicin—urinary bladder cancer	4.54e-05	0.000826	CcSEcCtD
Floxuridine—Anorexia—Methotrexate—urinary bladder cancer	4.52e-05	0.000823	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.51e-05	0.00128	CbGpPWpGaD
Floxuridine—Leukopenia—Doxorubicin—urinary bladder cancer	4.51e-05	0.00082	CcSEcCtD
Floxuridine—Confusional state—Epirubicin—urinary bladder cancer	4.48e-05	0.000815	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—EP300—urinary bladder cancer	4.45e-05	0.00126	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Epirubicin—urinary bladder cancer	4.44e-05	0.000808	CcSEcCtD
Floxuridine—Infection—Epirubicin—urinary bladder cancer	4.41e-05	0.000803	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—CCNE1—urinary bladder cancer	4.41e-05	0.00125	CbGpPWpGaD
Floxuridine—Nervous system disorder—Epirubicin—urinary bladder cancer	4.35e-05	0.000792	CcSEcCtD
Floxuridine—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.35e-05	0.000791	CcSEcCtD
Floxuridine—Discomfort—Doxorubicin—urinary bladder cancer	4.23e-05	0.00077	CcSEcCtD
Floxuridine—Anorexia—Epirubicin—urinary bladder cancer	4.23e-05	0.00077	CcSEcCtD
Floxuridine—Confusional state—Doxorubicin—urinary bladder cancer	4.14e-05	0.000754	CcSEcCtD
Floxuridine—Decreased appetite—Methotrexate—urinary bladder cancer	4.12e-05	0.00075	CcSEcCtD
Floxuridine—TYMS—Metabolism—TYMP—urinary bladder cancer	4.12e-05	0.00117	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	4.11e-05	0.000747	CcSEcCtD
Floxuridine—Infection—Doxorubicin—urinary bladder cancer	4.08e-05	0.000743	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.04e-05	0.00114	CbGpPWpGaD
Floxuridine—Nervous system disorder—Doxorubicin—urinary bladder cancer	4.03e-05	0.000733	CcSEcCtD
Floxuridine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	4.02e-05	0.000732	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.95e-05	0.00112	CbGpPWpGaD
Floxuridine—Anorexia—Doxorubicin—urinary bladder cancer	3.92e-05	0.000713	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTP1—urinary bladder cancer	3.91e-05	0.00111	CbGpPWpGaD
Floxuridine—Feeling abnormal—Methotrexate—urinary bladder cancer	3.91e-05	0.000711	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.88e-05	0.000706	CcSEcCtD
Floxuridine—Decreased appetite—Epirubicin—urinary bladder cancer	3.86e-05	0.000702	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	3.77e-05	0.00107	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TERT—urinary bladder cancer	3.77e-05	0.00107	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.76e-05	0.00107	CbGpPWpGaD
Floxuridine—Abdominal pain—Methotrexate—urinary bladder cancer	3.75e-05	0.000682	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—urinary bladder cancer	3.75e-05	0.000682	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.73e-05	0.00106	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NAT2—urinary bladder cancer	3.72e-05	0.00105	CbGpPWpGaD
Floxuridine—Feeling abnormal—Epirubicin—urinary bladder cancer	3.66e-05	0.000666	CcSEcCtD
Floxuridine—TYMP—Metabolism—TYMS—urinary bladder cancer	3.64e-05	0.00103	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.63e-05	0.000661	CcSEcCtD
Floxuridine—TYMP—Metabolism—NCOR1—urinary bladder cancer	3.59e-05	0.00102	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTM1—urinary bladder cancer	3.59e-05	0.00102	CbGpPWpGaD
Floxuridine—Decreased appetite—Doxorubicin—urinary bladder cancer	3.57e-05	0.00065	CcSEcCtD
Floxuridine—Abdominal pain—Epirubicin—urinary bladder cancer	3.51e-05	0.000639	CcSEcCtD
Floxuridine—Body temperature increased—Epirubicin—urinary bladder cancer	3.51e-05	0.000639	CcSEcCtD
Floxuridine—Hypersensitivity—Methotrexate—urinary bladder cancer	3.5e-05	0.000636	CcSEcCtD
Floxuridine—TYMP—Metabolism—GPX1—urinary bladder cancer	3.44e-05	0.000974	CbGpPWpGaD
Floxuridine—Asthenia—Methotrexate—urinary bladder cancer	3.4e-05	0.000619	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—ATM—urinary bladder cancer	3.39e-05	0.00096	CbGpPWpGaD
Floxuridine—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.39e-05	0.000616	CcSEcCtD
Floxuridine—TYMP—Metabolism—ERCC2—urinary bladder cancer	3.38e-05	0.000957	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDK4—urinary bladder cancer	3.38e-05	0.000956	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.36e-05	0.000611	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.32e-05	0.000939	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—RB1—urinary bladder cancer	3.28e-05	0.000929	CbGpPWpGaD
Floxuridine—Hypersensitivity—Epirubicin—urinary bladder cancer	3.27e-05	0.000595	CcSEcCtD
Floxuridine—Body temperature increased—Doxorubicin—urinary bladder cancer	3.25e-05	0.000591	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—urinary bladder cancer	3.25e-05	0.000591	CcSEcCtD
Floxuridine—Diarrhoea—Methotrexate—urinary bladder cancer	3.25e-05	0.000591	CcSEcCtD
Floxuridine—TYMS—Metabolism—RRM2—urinary bladder cancer	3.21e-05	0.00091	CbGpPWpGaD
Floxuridine—Asthenia—Epirubicin—urinary bladder cancer	3.19e-05	0.00058	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—TP53—urinary bladder cancer	3.18e-05	0.000902	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—MTHFR—urinary bladder cancer	3.18e-05	0.000899	CbGpPWpGaD
Floxuridine—Diarrhoea—Epirubicin—urinary bladder cancer	3.04e-05	0.000553	CcSEcCtD
Floxuridine—Hypersensitivity—Doxorubicin—urinary bladder cancer	3.03e-05	0.000551	CcSEcCtD
Floxuridine—Vomiting—Methotrexate—urinary bladder cancer	3.02e-05	0.000549	CcSEcCtD
Floxuridine—Rash—Methotrexate—urinary bladder cancer	2.99e-05	0.000544	CcSEcCtD
Floxuridine—Dermatitis—Methotrexate—urinary bladder cancer	2.99e-05	0.000544	CcSEcCtD
Floxuridine—TYMS—Metabolism—HPGDS—urinary bladder cancer	2.98e-05	0.000843	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ENO2—urinary bladder cancer	2.98e-05	0.000843	CbGpPWpGaD
Floxuridine—Headache—Methotrexate—urinary bladder cancer	2.97e-05	0.000541	CcSEcCtD
Floxuridine—Asthenia—Doxorubicin—urinary bladder cancer	2.95e-05	0.000536	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—RB1—urinary bladder cancer	2.93e-05	0.000831	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTT1—urinary bladder cancer	2.89e-05	0.000817	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	2.89e-05	0.000817	CbGpPWpGaD
Floxuridine—Vomiting—Epirubicin—urinary bladder cancer	2.82e-05	0.000514	CcSEcCtD
Floxuridine—Nausea—Methotrexate—urinary bladder cancer	2.82e-05	0.000513	CcSEcCtD
Floxuridine—Diarrhoea—Doxorubicin—urinary bladder cancer	2.81e-05	0.000511	CcSEcCtD
Floxuridine—Rash—Epirubicin—urinary bladder cancer	2.8e-05	0.000509	CcSEcCtD
Floxuridine—Dermatitis—Epirubicin—urinary bladder cancer	2.8e-05	0.000509	CcSEcCtD
Floxuridine—Headache—Epirubicin—urinary bladder cancer	2.78e-05	0.000506	CcSEcCtD
Floxuridine—Nausea—Epirubicin—urinary bladder cancer	2.64e-05	0.00048	CcSEcCtD
Floxuridine—Vomiting—Doxorubicin—urinary bladder cancer	2.61e-05	0.000475	CcSEcCtD
Floxuridine—Rash—Doxorubicin—urinary bladder cancer	2.59e-05	0.000471	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—urinary bladder cancer	2.59e-05	0.000471	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—CDKN2A—urinary bladder cancer	2.58e-05	0.00073	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPARG—urinary bladder cancer	2.58e-05	0.000729	CbGpPWpGaD
Floxuridine—Headache—Doxorubicin—urinary bladder cancer	2.57e-05	0.000468	CcSEcCtD
Floxuridine—TYMP—Metabolism—CREBBP—urinary bladder cancer	2.47e-05	0.000701	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—urinary bladder cancer	2.44e-05	0.000444	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	2.44e-05	0.00069	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NQO1—urinary bladder cancer	2.4e-05	0.000679	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	2.36e-05	0.000668	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—EP300—urinary bladder cancer	2.24e-05	0.000635	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—urinary bladder cancer	2.18e-05	0.000617	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1A—urinary bladder cancer	2.11e-05	0.000597	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—urinary bladder cancer	2.03e-05	0.000574	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—EP300—urinary bladder cancer	2.01e-05	0.000568	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTP1—urinary bladder cancer	2e-05	0.000566	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—urinary bladder cancer	1.96e-05	0.000554	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTM1—urinary bladder cancer	1.84e-05	0.000521	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NCOR1—urinary bladder cancer	1.84e-05	0.000521	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—urinary bladder cancer	1.77e-05	0.0005	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GPX1—urinary bladder cancer	1.76e-05	0.000498	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—urinary bladder cancer	1.75e-05	0.000495	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ERCC2—urinary bladder cancer	1.73e-05	0.000489	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—EP300—urinary bladder cancer	1.69e-05	0.000477	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—MTHFR—urinary bladder cancer	1.62e-05	0.00046	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—urinary bladder cancer	1.44e-05	0.000407	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPARG—urinary bladder cancer	1.32e-05	0.000373	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CREBBP—urinary bladder cancer	1.27e-05	0.000358	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—urinary bladder cancer	1.04e-05	0.000293	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—urinary bladder cancer	9.04e-06	0.000256	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—EP300—urinary bladder cancer	8.62e-06	0.000244	CbGpPWpGaD
